475 related articles for article (PubMed ID: 35483311)
1. The role of quorum sensing, biofilm formation, and iron acquisition as key virulence mechanisms in Acinetobacter baumannii and the corresponding anti-virulence strategies.
Law SKK; Tan HS
Microbiol Res; 2022 Jul; 260():127032. PubMed ID: 35483311
[TBL] [Abstract][Full Text] [Related]
2. Quorum-sensing system in Acinetobacter baumannii: a potential target for new drug development.
Saipriya K; Swathi CH; Ratnakar KS; Sritharan V
J Appl Microbiol; 2020 Jan; 128(1):15-27. PubMed ID: 31102552
[TBL] [Abstract][Full Text] [Related]
3. Understanding the biofilm development of Acinetobacter baumannii and novel strategies to combat infection.
Naseef Pathoor N; Viswanathan A; Wadhwa G; Ganesh PS
APMIS; 2024 May; 132(5):317-335. PubMed ID: 38444124
[TBL] [Abstract][Full Text] [Related]
4. [Investigation of the virulence factors of multidrug-resistant Acinetobacter baumannii isolates].
Eraç B; Yılmaz FF; Hoşgör Limoncu M; Oztürk I; Aydemir S
Mikrobiyol Bul; 2014 Jan; 48(1):70-81. PubMed ID: 24506717
[TBL] [Abstract][Full Text] [Related]
5. Novel approaches to overcome Colistin resistance in Acinetobacter baumannii: Exploring quorum quenching as a potential solution.
Khoshbakht R; Panahi S; Neshani A; Ghavidel M; Ghazvini K
Microb Pathog; 2023 Sep; 182():106264. PubMed ID: 37474078
[TBL] [Abstract][Full Text] [Related]
6. Synergistic Inhibitory Effect of Polymyxin B in Combination with Ceftazidime against Robust Biofilm Formed by Acinetobacter baumannii with Genetic Deficiency in AbaI/AbaR Quorum Sensing.
Li Y; Wang B; Lu F; Ahn J; Zhang W; Cai L; Xu J; Yin Y; Cao Q; Ren Z; He X
Microbiol Spectr; 2022 Feb; 10(1):e0176821. PubMed ID: 35196792
[TBL] [Abstract][Full Text] [Related]
7. [Current approaches to explain the virulence of Acinetobacter baumannii].
Aşık G
Mikrobiyol Bul; 2011 Apr; 45(2):371-80. PubMed ID: 21644082
[TBL] [Abstract][Full Text] [Related]
8. Drugs with new lease of life as quorum sensing inhibitors: for combating MDR Acinetobacter baumannii infections.
Seleem NM; Abd El Latif HK; Shaldam MA; El-Ganiny A
Eur J Clin Microbiol Infect Dis; 2020 Sep; 39(9):1687-1702. PubMed ID: 32328851
[TBL] [Abstract][Full Text] [Related]
9. Genomic and Phenotypic Evolution of Tigecycline-Resistant Acinetobacter baumannii in Critically Ill Patients.
Zhang J; Xie J; Li H; Wang Z; Yin Y; Wang S; Chen H; Wang Q; Wang H
Microbiol Spectr; 2022 Feb; 10(1):e0159321. PubMed ID: 35044218
[TBL] [Abstract][Full Text] [Related]
10. Acinetobacter baumannii: Pathogenesis, virulence factors, novel therapeutic options and mechanisms of resistance to antimicrobial agents with emphasis on tigecycline.
Dehbanipour R; Ghalavand Z
J Clin Pharm Ther; 2022 Nov; 47(11):1875-1884. PubMed ID: 36200470
[TBL] [Abstract][Full Text] [Related]
11. AbaM Regulates Quorum Sensing, Biofilm Formation, and Virulence in
López-Martín M; Dubern JF; Alexander MR; Williams P
J Bacteriol; 2021 Mar; 203(8):. PubMed ID: 33495249
[No Abstract] [Full Text] [Related]
12. Inhibition of Virulence Factors and Biofilm Formation of Acinetobacter Baumannii by Naturally-derived and Synthetic Drugs.
Bamunuarachchi NI; Khan F; Kim YM
Curr Drug Targets; 2021; 22(7):734-759. PubMed ID: 33100201
[TBL] [Abstract][Full Text] [Related]
13. Insights Into Mechanisms of Biofilm Formation in
Colquhoun JM; Rather PN
Front Cell Infect Microbiol; 2020; 10():253. PubMed ID: 32547965
[TBL] [Abstract][Full Text] [Related]
14. Fighting Acinetobacter baumannii infections with the acylase PvdQ.
Vogel J; Jansen L; Setroikromo R; Cavallo FM; van Dijl JM; Quax WJ
Microbes Infect; 2022 Jun; 24(4):104951. PubMed ID: 35151875
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
[TBL] [Abstract][Full Text] [Related]
16. Acinetobacter baumannii: An overview of emerging multidrug-resistant pathogen.
Gautam D; Dolma KG; Khandelwal B; Mitsuwan W; Mahboob T; Pereira ML; Nawaz M; Wiart C; Ardebili A; Siyadatpanah A; Ehtesham H; Patra JK; Kwanhian W; Nissapatorn V
Med J Malaysia; 2022 May; 77(3):357-370. PubMed ID: 35638493
[TBL] [Abstract][Full Text] [Related]
17. Iron limitation enhances acyl homoserine lactone (AHL) production and biofilm formation in clinical isolates of Acinetobacter baumannii.
Modarresi F; Azizi O; Shakibaie MR; Motamedifar M; Mosadegh E; Mansouri S
Virulence; 2015; 6(2):152-61. PubMed ID: 25622119
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic strategies against potential antibiofilm targets of multidrug-resistant Acinetobacter baumannii.
Kaushik V; Tiwari M; Joshi R; Tiwari V
J Cell Physiol; 2022 Apr; 237(4):2045-2063. PubMed ID: 35083758
[TBL] [Abstract][Full Text] [Related]
19.
Jha NK; Gopu V; Sivasankar C; Singh SR; Devi PB; Murali A; Shetty PH
J Med Microbiol; 2024 Mar; 73(3):. PubMed ID: 38506718
[No Abstract] [Full Text] [Related]
20. Antimicrobial and biofilm inhibiting potential of an amide derivative [N-(2', 4'-dinitrophenyl)-3β-hydroxyurs-12-en-28-carbonamide] of ursolic acid by modulating membrane potential and quorum sensing against colistin resistant Acinetobacter baumannii.
Usmani Y; Ahmed A; Faizi S; Versiani MA; Shamshad S; Khan S; Simjee SU
Microb Pathog; 2021 Aug; 157():104997. PubMed ID: 34048890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
